Skip to main content
Top
Published in: Gut Pathogens 1/2012

Open Access 01-11-2012 | Meeting report

Probiotics for human health –new innovations and emerging trends

Authors: Sunita Grover, Hogarehalli Mallapa Rashmi, Anil Kumar Srivastava, Virender Kumar Batish

Published in: Gut Pathogens | Issue 1/2012

Login to get access

Abstract

The role of the gut microbiome in human health and disease with a particular emphasis on therapeutic use of probiotics under specific medical conditions was mainly highlighted in 1st Annual conference of Probiotic Association of India (PAi) and International Symposium on “Probiotics for Human Health - New Innovations and Emerging Trends” held on 27th-28th August, 2012 at New Delhi, India. There is increasing recognition of the fact that dysbiosis or alteration of this gut microbiome may be implicated in gastro-intestinal disorders including diarrheal diseases, ulcerative colitis, inflammatory bowel diseases, life style diseases viz. Diabetes Mellitus-2 and obesity etc. This report summarizes the proceedings of the conference and the symposium comprehensively. Although, research on probiotics has been continuing for the past few decades, the subject has been currently the major focus of attention across the world due to recent advances and new developments in genomics, transcriptomics, proteomics, metabolomics and emergence of new generation of high through put sequencing technologies that have immensely helped in understanding the probiotic functionality and mode of action from nutritional and health perspectives. There is now sufficient evidence backed up with good quality scientific clinical data to suggest that probiotic interventions could indeed be effective in various types of diarrheal diseases, other chronic gastrointestinal inflammatory disorders like pouchitis, necrotizing entero-colitis, allergic responses and lactose intolerance etc. This report makes a modest attempt to give all the stake holders involved in development of probiotic based functional/health foods an overview of the current status of probiotics research at the Global and National level. The most crucial issues that emerged from the lead talks delivered by the eminent speakers from India and abroad were the major focus of discussions in different plenary and technical sessions. By discussing some of these issues from scientific perspectives, the conference could achieve its prime objective of disseminating the current knowledge on the prospects of probiotics as potential biotherapeutics in the management of human health and diseases.
Literature
1.
go back to reference Prajapati JB, Khedkar CD, Chitra J, Suja S, Mishra V, Sreeja V, Patel RK, Ahir VB, Bhatt VD, Sajnani MR, Sajnani MR, Jakhesara SJ, Koringa PG, Joshi CG: Whole-genome shotgun sequencing of an Indian-origin Lactobacillus helveticus strain, MTCC 5463, with probiotic potential. J Bacteriol. 2011, 193 (16): 4282-4283.PubMedCentralCrossRefPubMed Prajapati JB, Khedkar CD, Chitra J, Suja S, Mishra V, Sreeja V, Patel RK, Ahir VB, Bhatt VD, Sajnani MR, Sajnani MR, Jakhesara SJ, Koringa PG, Joshi CG: Whole-genome shotgun sequencing of an Indian-origin Lactobacillus helveticus strain, MTCC 5463, with probiotic potential. J Bacteriol. 2011, 193 (16): 4282-4283.PubMedCentralCrossRefPubMed
2.
go back to reference Duary RK, Batish VK, Grover S: Expression of the atpD gene in probiotic Lactobacillus plantarum strains under in vitro acidic conditions using RT-qPCR. Res Microbiol. 2010, 161 (5): 399-405.CrossRefPubMed Duary RK, Batish VK, Grover S: Expression of the atpD gene in probiotic Lactobacillus plantarum strains under in vitro acidic conditions using RT-qPCR. Res Microbiol. 2010, 161 (5): 399-405.CrossRefPubMed
3.
go back to reference Duary RK, Batish V, Grover S: Relative gene expression of bile salt hydrolase and surface proteins in two putative indigenous Lactobacillus plantarum strains under in vitro gut conditions. Mol Biol Rep. 2012, 39 (3): 2541-2552.CrossRefPubMed Duary RK, Batish V, Grover S: Relative gene expression of bile salt hydrolase and surface proteins in two putative indigenous Lactobacillus plantarum strains under in vitro gut conditions. Mol Biol Rep. 2012, 39 (3): 2541-2552.CrossRefPubMed
4.
go back to reference Duary RK, Bhausaheb MA, Batish VK, Grover S: Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep. 2012, 39 (4): 4765-4775.CrossRefPubMed Duary RK, Bhausaheb MA, Batish VK, Grover S: Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep. 2012, 39 (4): 4765-4775.CrossRefPubMed
5.
go back to reference Duary RK, Rajput YS, Batish VK, Grover S: Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. Indian J Med Res. 2011, 134: 664-671.PubMedCentralCrossRefPubMed Duary RK, Rajput YS, Batish VK, Grover S: Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. Indian J Med Res. 2011, 134: 664-671.PubMedCentralCrossRefPubMed
6.
go back to reference Kumar H, Rangrez A, Dayananda K, Atre A, Patole M, Shouche Y: Lactobacillus plantarum (VR1) isolated from an Ayurvedic medicine (Kutajarista) ameliorates in vitro cellular damage caused by Aeromonas veronii. BMC Microbiol. 2011, 11 (1): 152.PubMedCentralCrossRefPubMed Kumar H, Rangrez A, Dayananda K, Atre A, Patole M, Shouche Y: Lactobacillus plantarum (VR1) isolated from an Ayurvedic medicine (Kutajarista) ameliorates in vitro cellular damage caused by Aeromonas veronii. BMC Microbiol. 2011, 11 (1): 152.PubMedCentralCrossRefPubMed
7.
go back to reference Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL: Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Clin Infect Dis. 2008, 46 (2): S53-S57.CrossRefPubMed Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL: Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Clin Infect Dis. 2008, 46 (2): S53-S57.CrossRefPubMed
8.
9.
go back to reference Rautava S, Luoto R, Salminen S, Isolauri E: Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol. 2012, 9 (10): 565-576.CrossRefPubMed Rautava S, Luoto R, Salminen S, Isolauri E: Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol. 2012, 9 (10): 565-576.CrossRefPubMed
10.
go back to reference Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A: The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012, 96 (3): 544-551.CrossRefPubMed Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A: The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012, 96 (3): 544-551.CrossRefPubMed
11.
go back to reference van Loveren H, Sanz Y, Salminen S: Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol. 2012, 3: 247-261.CrossRefPubMed van Loveren H, Sanz Y, Salminen S: Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol. 2012, 3: 247-261.CrossRefPubMed
12.
go back to reference Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity, stability and resilience of the human gut microbiota. Nat. 2012, 489 (7415): 220-230.CrossRef Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity, stability and resilience of the human gut microbiota. Nat. 2012, 489 (7415): 220-230.CrossRef
13.
go back to reference Vyas U, Ranganathan N: Probiotics, prebiotics and synbiotics: Gut and beyond. Gastroenterol Res Pract. 2012, 2012: 1-16.CrossRef Vyas U, Ranganathan N: Probiotics, prebiotics and synbiotics: Gut and beyond. Gastroenterol Res Pract. 2012, 2012: 1-16.CrossRef
14.
go back to reference Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous Clostridium Species. Sci. 2011, 331 (6015): 337-341.CrossRef Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous Clostridium Species. Sci. 2011, 331 (6015): 337-341.CrossRef
15.
go back to reference Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA: Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006, 3: 275-284.CrossRefPubMed Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA: Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006, 3: 275-284.CrossRefPubMed
16.
go back to reference Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD: Linking long-term dietary patterns with gut microbial enterotypes. Sci. 2011, 334 (6052): 105-108.CrossRef Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD: Linking long-term dietary patterns with gut microbial enterotypes. Sci. 2011, 334 (6052): 105-108.CrossRef
17.
go back to reference McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard C, Heath AC, Gordon JI: The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011, 3 (106): 106.CrossRef McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard C, Heath AC, Gordon JI: The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011, 3 (106): 106.CrossRef
18.
go back to reference Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010, 5 (2): e9085.PubMedCentralCrossRefPubMed Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010, 5 (2): e9085.PubMedCentralCrossRefPubMed
20.
go back to reference Sanz Y: Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr. 2011, 94 (6): 2000S-2005S.CrossRefPubMed Sanz Y: Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr. 2011, 94 (6): 2000S-2005S.CrossRefPubMed
22.
go back to reference Sur D, Manna B, Niyogi SK, Ramamurthy T, Palit A, Nomoto K, Takahashi T, Shima T, Tsuji H, Kurakawa T, Takeda Y, Nair GB, Bhattacharya SK: Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2011, 139 (06): 919-926.CrossRefPubMed Sur D, Manna B, Niyogi SK, Ramamurthy T, Palit A, Nomoto K, Takahashi T, Shima T, Tsuji H, Kurakawa T, Takeda Y, Nair GB, Bhattacharya SK: Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2011, 139 (06): 919-926.CrossRefPubMed
23.
go back to reference Grosfeld JL, Chaedt M, Molinari F: Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996, 224 (3): 350-357.PubMedCentralCrossRefPubMed Grosfeld JL, Chaedt M, Molinari F: Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996, 224 (3): 350-357.PubMedCentralCrossRefPubMed
24.
go back to reference Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, YehTF OW: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Paediatr. 2005, 115 (1): 1-4. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, YehTF OW: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Paediatr. 2005, 115 (1): 1-4.
25.
go back to reference Deshpande G, Rao S, Patole S, Bulsara M: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Paediatr. 2010, 125 (5): 921-930.CrossRef Deshpande G, Rao S, Patole S, Bulsara M: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Paediatr. 2010, 125 (5): 921-930.CrossRef
26.
go back to reference Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X: Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5: 220-230.PubMedCentralCrossRefPubMed Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X: Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5: 220-230.PubMedCentralCrossRefPubMed
27.
go back to reference Corr SC, Li Y, Riedel CU, O’Toole PW, Hill C, Gahan CGM: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci. 2007, 104 (18): 7617-7621.PubMedCentralCrossRefPubMed Corr SC, Li Y, Riedel CU, O’Toole PW, Hill C, Gahan CGM: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci. 2007, 104 (18): 7617-7621.PubMedCentralCrossRefPubMed
28.
go back to reference Rea MC, Sit CS, Clayton E, O’Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C: Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci. 2010, 107 (20): 9352-9357.PubMedCentralCrossRefPubMed Rea MC, Sit CS, Clayton E, O’Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C: Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci. 2010, 107 (20): 9352-9357.PubMedCentralCrossRefPubMed
29.
go back to reference Garg KB, Ganguli I, Kriplani A, Lohiya NK, Thulkar J, Talwar GP: Metabolic properties of lactobacilli in women experiencing recurring episodes of bacterial vaginosis with vaginal pH ≥ 5. Eur J Clin Microbiol Infect Dis. 2010, 29 (1): 123-125.CrossRefPubMed Garg KB, Ganguli I, Kriplani A, Lohiya NK, Thulkar J, Talwar GP: Metabolic properties of lactobacilli in women experiencing recurring episodes of bacterial vaginosis with vaginal pH ≥ 5. Eur J Clin Microbiol Infect Dis. 2010, 29 (1): 123-125.CrossRefPubMed
30.
go back to reference Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006, 6 (6): 374-382.CrossRefPubMed Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006, 6 (6): 374-382.CrossRefPubMed
31.
go back to reference Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EMM: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010, 59 (3): 325-332.CrossRefPubMed Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EMM: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010, 59 (3): 325-332.CrossRefPubMed
32.
go back to reference Holubar SD, Cima RR, Sandborn WJ, Pardi DS: Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2010, 6: CD001176.PubMed Holubar SD, Cima RR, Sandborn WJ, Pardi DS: Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2010, 6: CD001176.PubMed
33.
go back to reference Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ: Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS One. 2010, 5 (12): e15591.PubMedCentralCrossRefPubMed Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ: Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS One. 2010, 5 (12): e15591.PubMedCentralCrossRefPubMed
34.
go back to reference Ford AC, Moayyedi P: Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010, 32 (2): 144-158.CrossRefPubMed Ford AC, Moayyedi P: Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010, 32 (2): 144-158.CrossRefPubMed
35.
go back to reference Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE: Dose–response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011, 46 (9): 1057-1064.PubMedCentralCrossRefPubMed Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE: Dose–response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011, 46 (9): 1057-1064.PubMedCentralCrossRefPubMed
Metadata
Title
Probiotics for human health –new innovations and emerging trends
Authors
Sunita Grover
Hogarehalli Mallapa Rashmi
Anil Kumar Srivastava
Virender Kumar Batish
Publication date
01-11-2012
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2012
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/1757-4749-4-15

Other articles of this Issue 1/2012

Gut Pathogens 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.